PHYSIO2ME LIMITED

Company Registration Number:
06855264 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2025

Period of accounts

Start date: 1 April 2024

End date: 31 March 2025

PHYSIO2ME LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Profit and loss
Balance sheet
Additional notes
Balance sheet notes

PHYSIO2ME LIMITED

Profit And Loss Account

for the Period Ended 31 March 2025

2025 2024


£

£
Turnover: (2,284) (2,917)
Cost of sales: ( 52 ) 0
Gross profit(or loss): (2,336) (2,917)
Distribution costs: 0 0
Administrative expenses: 0 0
Other operating income: 0 0
Operating profit(or loss): (2,336) (2,917)
Interest receivable and similar income: 0 0
Interest payable and similar charges: 0 0
Profit(or loss) before tax: (2,336) (2,917)
Tax: 0 0
Profit(or loss) for the financial year: (2,336) (2,917)

PHYSIO2ME LIMITED

Balance sheet

As at 31 March 2025

Notes 2025 2024


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks:   0 0
Debtors: 3 1,050 1,050
Cash at bank and in hand: 2,142 2,412
Investments:   0 0
Total current assets: 3,192 3,462
Prepayments and accrued income: 147 2,284
Creditors: amounts falling due within one year: 4 ( 2,228 ) ( 2,299 )
Net current assets (liabilities): 1,111 3,447
Total assets less current liabilities: 1,111 3,447
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): 1,111 3,447
Capital and reserves
Called up share capital: 1,050 1,050
Profit and loss account: 61 2,397
Total Shareholders' funds: 1,111 3,447

The notes form part of these financial statements

PHYSIO2ME LIMITED

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 2 June 2025
and signed on behalf of the board by:

Name: Nick Stone
Status: Director

The notes form part of these financial statements

PHYSIO2ME LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    1.2 Going concern At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements. 1.3 Turnover Turnover is recognised at the fair value of the consideration received or receivable for physiotherapy services provided in the normal course of business.

    Other accounting policies

    1.4 Cash and cash equivalents Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities 1.5 Financial Instruments Trade Debtors Debtors do not carry any interest and are stated at their nominal value Trade Creditors Trade creditors are not interest bearing and are stated at their nominal value. 1.6 Equity Instruments Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company. 1.7 Taxation The tax expense represents the sum of the tax currently payable and deferred tax. Current tax The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date. 1.8 Employee benefits The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets. The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received. Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits. 2 Judgements and key sources of estimation uncertainty In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. The directors consider there to be no key sources of estimation uncertainty.

PHYSIO2ME LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 4 4

PHYSIO2ME LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Debtors

2025 2024
£ £
Other debtors 1,050 1,050
Total 1,050 1,050
Debtors due after more than one year: 0 0

PHYSIO2ME LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Creditors: amounts falling due within one year note

2025 2024
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 2,228 2,299
Taxation and social security 0 0
Accruals and deferred income 0
Other creditors 0
Total 2,228 2,299